http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023275648-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c965b76827e500120c872ebf22a51655 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-11 |
| filingDate | 2022-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec212fd5e22c624746a4802038ff979 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c8c619b9aeb2f739483744473aebfcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f223e0344a06cf594f000487a6456a45 |
| publicationDate | 2023-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2023275648-A1 |
| titleOfInvention | Compositions and methods for using alternating electric fields to disrupt lipid capsules |
| abstract | Disclosed are methods of delivering a therapeutic to a target site of a subject comprising administering a lipid capsule to a target site of a subject, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field, at a frequency for a period of time, to the target site of the subject, wherein the alternating electric field releases the therapeutic from lipid capsule at the target site of the subject. Disclosed are methods of increasing target site specific release of a therapeutic agent in a subject comprising administering a lipid capsule to a target site of a subject, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field, at a frequency for a period of time, to the target site of the subject, wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site of the subject, thereby increasing the target site specific release of the therapeutic agent. Disclosed are methods of treating comprise administering a lipid capsule to a target site of a subject in need thereof, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field, at a frequency for a period of time, to the target site of the subject in need thereof, wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site of the subject in need thereof. Disclosed are methods of killing a cell comprising administering a lipid capsule to a target site, wherein the lipid capsule comprises a therapeutic agent; and applying an alternating electric field for a period of time, to the target site, wherein the alternating electric field releases the therapeutic agent from the lipid capsule at the target site, wherein the target site comprises a cell, wherein the therapeutic kills the cell. |
| priorityDate | 2021-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.